Publikationen (23) Publikationen, an denen Forscher/innen teilgenommen haben

2010

  1. Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options?

    Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 8, pp. 484-488

  2. Biochemical determination of lipid content in hepatic steatosis by the Soxtec method

    World Journal of Gastroenterology, Vol. 16, Núm. 12, pp. 1495-1499

  3. Characteristics of patients with familial adenomatous polyposis in Spain. First results of the Spanish Registry of Familial Adenomatous Polyposis

    Medicina Clinica, Vol. 135, Núm. 3, pp. 103-108

  4. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

  5. Disease-specific health-related quality of life in patients with esophageal achalasia before and after therapy

    Neurogastroenterology and Motility, Vol. 22, Núm. 7, pp. 739-745

  6. Estrés oxidativo en el infarto cerebral

    Revista Electrónica de Biomedicina, Núm. 3, pp. 21-26

  7. Inflammatory mediators of hepatic steatosis

    Mediators of Inflammation, Vol. 2010

  8. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

    Gut, Vol. 59, Núm. 10, pp. 1340-1346

  9. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer

    Clinical Cancer Research, Vol. 16, Núm. 22, pp. 5402-5413

  10. Malignant colorectal polyps

    World Journal of Gastroenterology, Vol. 16, Núm. 25, pp. 3103-3111

  11. Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation

    Transplantation Proceedings, Vol. 42, Núm. 2, pp. 660-662

  12. Niveles de tiorredoxina plasmática en individuos sanos adultos

    Revista Electrónica de Biomedicina, Núm. 2, pp. 12-17

  13. Niveles plasmóticos de la vitamina B12 y ácido fólicoenpacientes con hepatopatía crónica

    Gastroenterologia y Hepatologia, Vol. 33, Núm. 4, pp. 280-287

  14. No evidence for JAK2 V617F mutation in colorectal cancer

    British Journal of Biomedical Science, Vol. 67, Núm. 4, pp. 220-222

  15. P73 deficiency results in impaired self renewal and premature neuronal differentiation of mouse neural progenitors independently of p53

    Cell Death and Disease, Vol. 1, Núm. 12

  16. Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma

    Gastroenterologia y Hepatologia, Vol. 33, Núm. 10, pp. 741-752

  17. Significance of H63D homozygosity in a Basque population with hemochromatosis

    Journal of Gastroenterology and Hepatology (Australia), Vol. 25, Núm. 7, pp. 1295-1298

  18. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype

    Gastroenterology, Vol. 139, Núm. 3

  19. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: Results at 1 year

    Digestive and Liver Disease, Vol. 42, Núm. 6, pp. 432-435

  20. TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status

    Journal of Translational Medicine, Vol. 8